Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.01
-0.03-1.47%
Last update: Oct 22, 4:48 PM
$2.00
-0.04-1.96%
Foghorn Therapeutics Inc (FHTX) Stock Price, Quote, News & History
FHTXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Foghorn Therapeutics (NASDAQ:FHTX) through any online brokerage.
Other companies in Foghorn Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Foghorn Therapeutics has a consensus price target of $10.33.
The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $2 last updated October 22, 2026 at 4:48 PM EDT.
There are no upcoming dividends for Foghorn Therapeutics.
Foghorn Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Foghorn Therapeutics.
Foghorn Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
